In a groundbreaking 84-week-long study, researchers found that tirzepatide, a medication initially designed for treating type 2 diabetes, significantly bolstered weight loss in overweight and obese patients already on intensive lifestyle programs. While the drug showed promise in further reducing body weight and improving cardiometabolic factors, mild to moderate gastrointestinal side effects were the most common drawback.
3D-printed bone: Biomimetic scaffolds offer hope for cranial defect repair
The cranial bone in the human body performs very important functions, such as protecting the brain and enabling the passage of the cranial nerves that
December 22, 2023